332 related articles for article (PubMed ID: 35237164)
1. Antibiotic Use in China's Public Healthcare Institutions During the COVID-19 Pandemic: An Analysis of Nationwide Procurement Data, 2018-2020.
Yang Y; Geng X; Liu X; Wen X; Wu R; Cui D; Mao Z
Front Pharmacol; 2022; 13():813213. PubMed ID: 35237164
[No Abstract] [Full Text] [Related]
2. Antibiotic use in township hospitals during the COVID-19 pandemic in Shandong, China.
Wang T; Shen L; Yin J; Zhou L; Sun Q
Antimicrob Resist Infect Control; 2022 Dec; 11(1):164. PubMed ID: 36566210
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Antibiotic Use Patterns and Trends Based on Procurement Data of Healthcare Institutions in Shaanxi Province, Western China, 2015-2018.
Xu S; Yuan S; Kabba JA; Chen C; Liu W; Chang J; Fang Y
Int J Environ Res Public Health; 2020 Oct; 17(20):. PubMed ID: 33081253
[TBL] [Abstract][Full Text] [Related]
4. Antibiotics (Macrolides and Lincosamides) Consumption Trends and Patterns in China's Healthcare Institutes. Based on a 3 Year Procurement Records, 2015-2017.
Liu W; Hassan Gillani A; Xu S; Chen C; Chang J; Yang C; Ji W; Jiang M; Zhao M; Fang Y
Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33375251
[TBL] [Abstract][Full Text] [Related]
5. Secular trend analysis of antibiotic utilisation in China's hospitals 2011-2018, a retrospective analysis of procurement data.
Wushouer H; Zhou Y; Zhang X; Fu M; Fan D; Shi L; Guan X
Antimicrob Resist Infect Control; 2020 Apr; 9(1):53. PubMed ID: 32295639
[TBL] [Abstract][Full Text] [Related]
6. Long-term trend of antibiotic use at public health care institutions in northwest China, 2012-20 -- a case study of Gansu Province.
Cao W; Feng H; Ma Y; Zhao D; Hu X
BMC Public Health; 2023 Jan; 23(1):27. PubMed ID: 36604660
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic consumption in Shandong Province, China: an analysis of provincial pharmaceutical centralized bidding procurement data at public healthcare institutions, 2012-16.
Yin J; Li Q; Sun Q
J Antimicrob Chemother; 2018 Mar; 73(3):814-820. PubMed ID: 29272452
[TBL] [Abstract][Full Text] [Related]
8. The change of drug utilization in China's public healthcare institutions under the "4 + 7" centralized drug procurement policy: Evidence from a natural experiment in China.
Lu J; Long H; Shen Y; Wang J; Geng X; Yang Y; Mao Z; Li J
Front Pharmacol; 2022; 13():923209. PubMed ID: 36081942
[No Abstract] [Full Text] [Related]
9. Trends and patterns of antibiotic consumption in China's tertiary hospitals: Based on a 5 year surveillance with sales records, 2011-2015.
Wushouer H; Tian Y; Guan XD; Han S; Shi LW
PLoS One; 2017; 12(12):e0190314. PubMed ID: 29281716
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic Consumption Trends in China: Evidence From Six-Year Surveillance Sales Records in Shandong Province.
Song Y; Han Z; Song K; Zhen T
Front Pharmacol; 2020; 11():491. PubMed ID: 32362828
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic Expenditure by Public Healthcare Institutions in Shandong Province in China, 2012-2016.
Yin J; Wu C; Wei X; Sun Q
Front Pharmacol; 2018; 9():1396. PubMed ID: 30559665
[No Abstract] [Full Text] [Related]
12. Antibiotic Sales in Primary Care in Hubei Province, China: An Analysis of 2012-2017 Procurement Records.
Zhang X; Cui Y; Liu C; Zuo K; Tang Y
Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31547325
[TBL] [Abstract][Full Text] [Related]
13. Trends in the utilization of psychotropic medications in China from 2018 to 2021.
Zhang X; Hu X; Zhao Y; Lu CY; Nie X; Shi L
Front Pharmacol; 2022; 13():967826. PubMed ID: 36160455
[No Abstract] [Full Text] [Related]
14. Effect of a national antibiotic stewardship intervention in China targeting carbapenem overuse: An interrupted time-series analysis.
Xu S; Kitchen C; Liu Y; Kabba JA; Hayat K; Wang X; Wang G; Zhang F; Chang J; Fang Y; Wagner AK; Ross-Degnan D
Int J Antimicrob Agents; 2023 Oct; 62(4):106936. PubMed ID: 37517625
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic consumption and antimicrobial resistance in the SARS-CoV-2 pandemic: A single-center experience.
Sokolović D; Drakul D; Vujić-Aleksić V; Joksimović B; Marić S; Nežić L
Front Pharmacol; 2023; 14():1067973. PubMed ID: 37007038
[No Abstract] [Full Text] [Related]
16. The impact of the COVID-19 pandemic on antibiotic consumption and prevalence of pathogens in primary and secondary healthcare settings in Northern Ireland.
Aldeyab MA; Crowe W; Karasneh RA; Patterson L; Sartaj M; Ewing J; Lattyak WJ; Al-Azzam S; Araydah M; Darwish Elhajji F; Kabbaha S; Conway BR; Conlon-Bingham G; Farren D; Scott M
Br J Clin Pharmacol; 2023 Sep; 89(9):2851-2866. PubMed ID: 37160725
[TBL] [Abstract][Full Text] [Related]
17. Consumption of antibiotics in Chinese public general tertiary hospitals (2011-2014): Trends, pattern changes and regional differences.
Qu X; Yin C; Sun X; Huang S; Li C; Dong P; Lu X; Zhang Z; Yin A
PLoS One; 2018; 13(5):e0196668. PubMed ID: 29723230
[TBL] [Abstract][Full Text] [Related]
18. Trends and patterns of antibiotic using from 2014 to 2018 in stomatology hospitals of China.
Guo Z; Zhou Y; Fu M; Zheng L; Shi L
Oral Dis; 2024 Jun; ():. PubMed ID: 38888035
[TBL] [Abstract][Full Text] [Related]
19. The Persistence and Change in China's Healthcare Insurance Reform: Clues from Fiscal Subsidy Policies Made for Settling COVID-19 Patients' Medical Costs.
Ma T; Guo B; Xu J
Risk Manag Healthc Policy; 2022; 15():1129-1144. PubMed ID: 35637742
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial utilization in an Iraqi province: a comprehensive evaluation of antibiotic source and cost.
Al-Jumaili AA; Hussein AH; Al-Rekabi MD; Raheem SA; Ernst EJ
Int J Pharm Pract; 2017 Feb; 25(1):81-88. PubMed ID: 28097722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
